
Haemonetics (HAE) Market Capitalization Overview
Market Cap: $3.37B as of Jun 13, 2025
$3.37B
Past Month-$118.57M (3.40%)
As of Jun 13, 2025, Haemonetics (HAE) has a market capitalization of $3.37B. Over the past 30 days, its market cap has increased by 4.42%, while in the last 12 months, it has decreased by -14.14%.
Market capitalization represents the total value of Haemonetics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Haemonetics (HAE) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Haemonetics (HAE) helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Haemonetics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Haemonetics (HAE) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Haemonetics (HAE) helps investors assess the company's size and compare it with competitors for better investment decisions.
Haemonetics (HAE) Market Cap & Key Trends
See Haemonetics’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in Haemonetics (HAE)
Order type
Buy in
Order amount
Est. shares
0 shares
Haemonetics (HAE) Market Cap History
Date | Market Cap | Change |
---|---|---|
Jun 2, 2025 | $3.31B | +4.42% |
May 1, 2025 | $3.17B | -0.05% |
Apr 1, 2025 | $3.17B | -3.17% |
Mar 3, 2025 | $3.27B | -1.59% |
Feb 3, 2025 | $3.33B | -15.63% |
Jan 2, 2025 | $3.94B | -10.38% |
Haemonetics (HAE) End of Year Market Cap History
Date | Market Cap | Change |
---|---|---|
2025 | $3.37B | -14.14% |
2024 | $3.93B | -9.62% |
2023 | $4.34B | +9.01% |
2022 | $3.99B | +46.84% |
2021 | $2.72B | -55.05% |
2020 | $6.03B | — |
FAQs About Haemonetics (HAE) Market Cap
As of Jun 13, 2025, the market capitalization of Haemonetics (HAE) is $3.37B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Haemonetics’s market capitalization has decreased by -3.40%, changing from $3.49B to $3.37B as of Jun 13, 2025.
In the last 3 months, Haemonetics’s market capitalization has increased by —, changing from – to – as of –.
In the year 2024, Haemonetics’s market capitalization decreased from $4.34B in January to $3.93B in December, reflecting a -9.62% change.
In the past five years, Haemonetics (HAE) has had a compound annual growth rate (CAGR) of -8.25% in market capitalization. This means its market cap has shrunk at an average rate of -8.25% per year.